# AbTx

> novel oncology drug conjugates

Business model and tags: Pharma & life sciences, Has in-house R&D

## About AbTx

Developing next generation oncology treatments for incurable cancers, utilizing innovative enzymatic conjugation to generate antibody fragment drug conjugates for solid tumors.

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1–10 employees
- **Headquarters**: Dijon, Nouvelle-Aquitaine, France
- **Founded**: 2024
- **Revenue**: Early-stage startup (no revenue figure)
- **Website**: [abtx-bio.com](abtx-bio.com)
- **LinkedIn**: [linkedin.com/company/abtx](https://www.linkedin.com/company/abtx)

## AbTx at a glance

AbTx is a company in the Biotechnology Research industry, headquartered in Dijon, Nouvelle-Aquitaine, France.

AbTx was founded in 2024.

AbTx has 1–10 employees.

## Frequently asked questions about AbTx

### How many employees does AbTx have?

AbTx has 1–10 employees.

### Where is AbTx headquartered?

AbTx is headquartered in Dijon, Nouvelle-Aquitaine, France.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/abtx